NIKORANDIL V KLINIChESKOY PRAKTIKE KARDIOLOGA (REFERATIVNYY OBZOR)


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Full Text

Restricted Access

About the authors

- -

References

  1. Kinoshita M, Sakai K. Pharmacology and Therapeutic Effects of Nicorandil. Cardiovasc Drugs Ther 1990;4:1075-88.
  2. Meany TB, Richardson P, Camm AJ, et al. Exercise capacity after single and twice-daily doses of nicorandil in chronic stable angina pectoris. Amer J Cardiology 1989;63:66-70.
  3. Sakamoto T, Kaikita K, Miyamoto S, et al. Effects of nicorandil on endogenous fibrinolytic capacity in patients with coronary artery disease. CircJ 2004;68:232-56.
  4. Izumiya Y, Kojima S, Araki S, et al. Long-term use of oral nicorandil stabilizes coronary plaque in patients with stable angina pectoris. Atherosclerosis 2011;214(2):415-21.
  5. Sekiya M, Sato M, Funada J, Ohtani T, et al. Effects of the long-term administration of nicorandil on vascular endothelial function and the progression of arteriosclerosis. J Cardiovasc Pharmaco. 2005;46( 1 ):63-7.
  6. Kasama S, Toyama T, Sumino H, et al. Long-term nicorandil therapy improves cardiac sympathetic nerve activity after reperfusion therapy in patients with first acute myocardial infarction. J Nucl Med 2007;48( 10): 1676-82.
  7. Kasama S, Toyama T, Hatori T, et al. Comparative effects of nicorandil with isosorbide mononitrate on cardiac sympathetic nerve activity and left ventricular function in patients with ischemic cardiomyopathy. Am Heart J 2005;150(3):477.e1-477.e8.
  8. The IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 2002;359:1269-75.
  9. Horinaka S, Yabe A, Yagi H, et al. Effects of nicorandil on cardiovascular events in patients with coronary artery disease in the Japanese Coronary Artery Disease (JCAD) study. Circ J 2010;74(3):503-09.
  10. Sakata Y, Nakatani D, Shimizu M, et al. Oral treatment with nicorandil at discharge is associated with reduced mortality after acute myocardial infarction. J Cardiol 2012;59(1):14-21.
  11. Диагностика и лечение стабильной стенокардии. Российские рекомендации (второй пересмотр). ВНОК// Кардиоваскулярная терапия и профилактика 2008. № 7(6). Прил. 4. С. 33.
  12. National Institute for Health and Clinical Excellence. UK. Clinical guideline 126: Management of stable angina July 2011:14-5.
  13. Кардиоваскулярная профилактика. Национальные рекомендации. ВНОК // Кардиоваскулярная терапия и профилактика 2011. № 10(6). Прил. 2. С. 57.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies